(Q35146132)

6 August 2017

1 reference

title

Schizophrenia: from phenomenology to neurobiology (English)

1 reference

6 August 2017

0 references

Albert Hung Choy Wong

object named as

Albert Hung Choy Wong

series ordinal

1

1 reference

ORCID Public Data File 2021

author name string

Hubert H M Van Tol

series ordinal

2

1 reference

6 August 2017

1 May 2003

1 reference

Neuroscience & Biobehavioral Reviews

6 August 2017

1 reference

6 August 2017

27

1 reference

6 August 2017

3

1 reference

6 August 2017

269-306

1 reference

Catching up on schizophrenia: natural history and neurobiology

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia as the price that Homo sapiens pays for language: a resolution of the central paradox in the origin of the species

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: syndromes and diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenic syndromes in epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The coming Kuhnian revolution in biology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The theory of everything

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

1 reference

7 January 2021

Nithsdale Schizophrenia Surveys. 20. Cognitive function in a catchment-area-based population of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Symptoms, signs, and diagnosis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Comparison of delusions among schizophrenics in Austria and in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Comparison of schizophrenic delusions between Japan and Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: the fundamental questions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Validity of the negative/positive dichotomy of schizophrenic disorders under long-term conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Epidemiology of schizophrenia: the global burden of disease and disability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Outcome of schizophrenia in India using various diagnostic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A program for relapse prevention in schizophrenia: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Costs of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

1 reference

7 January 2021

A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The economic burden of schizophrenia in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

1 reference

7 January 2021

The neuropathology of schizophrenia. A critical review of the data and their interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: a neuropathological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Quantitative Brain Measurements in Chronic Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Limbic structures and lateral ventricle in schizophrenia. A quantitative postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Post-mortem study of chronic schizophrenic brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Limbic pathology in schizophrenia: the entorhinal region--a morphometric study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Postmortem studies of the hippocampal formation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia--a post-mortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Widespread cerebral gray matter volume deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cortical gray matter volume deficit in patients with first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

MRI anatomy of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gliosis in schizophrenia: a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The Brain Stem in Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gliosis in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neuropathology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Astrocytosis in the molecular layer of the dentate gyrus: a study in Alzheimer's disease and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Synaptic degeneration in thalamus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cytoarchitecture of the entorhinal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regional cerebral blood flow in schizophrenic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Reversibility of hemodynamic hypofrontality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

SNAP-25 deficit and hippocampal connectivity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Life expectancies for individuals with psychiatric diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cerebral gray matter volume deficits in first episode psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Meta-analysis of brain and cranial size in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Temporal lobe abnormalities in multigenerational families with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Brain changes in schizophrenia. Volumetric MRI study of families multiply affected with schizophrenia--the Maudsley Family Study 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cortical gyral anatomy and gross brain dimensions in monozygotic twins discordant for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cerebral ventricular size in twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Decreased left frontal lobe N-acetylaspartate in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurobiological investigations in cingulate cortex of schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Parallel distributed processing and the emergence of schizophrenic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Psychosis associated with demonstrable brain disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine D2 densities and the schizophrenic brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Multiplicity of mechanisms of serotonin receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

[3H]WAYâ 100635 for 5â HT1A receptor autoradiography in human brain: a comparison with [3H]8â OHâ DPAT and demonstration of increased binding in the frontal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

NMDA receptor regulation of memory and behavior in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The phencyclidine-glutamate model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A revised excitotoxic hypothesis of schizophrenia: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A two-process theory of schizophrenia: evidence from studies in post-mortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia and glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Functional neuroimaging in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Patterns of metabolic activity in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neural correlates of memory organization deficits in schizophrenia. A single photon emission computed tomography study with 99mTc-ethyl-cysteinate dimer during a verbal learning task.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Toward a brain map of auditory hallucinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Increased blood flow in Broca's area during auditory hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A compensatory mirror cortical mechanism for facial affect processing in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

An fMRI study of facial emotion processing in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A functional anatomic study of emotion in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Combinatorial expression patterns of LIM-homeodomain and other regulatory genes parcellate developing thalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Exploring and explaining epigenetic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase IIbeta in frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Increased expression of Wnt-1 in schizophrenic brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A decrease of reelin expression as a putative vulnerability factor in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Mitochondrial involvement in schizophrenia and other functional psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Abnormal expression of cell recognition molecules in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Application of cDNA microarrays to examine gene expression differences in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurocognitive deficits and neurological signs in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Disturbed voluntary motor activity in schizophrenic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Processing of auditory stimuli during visual attention in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia and cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Working memory dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Word recall in schizophrenia: a connectionist model.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dependence of impaired eye tracking on deficient velocity discrimination in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Emotion processing and its relationship to social functioning in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Interacting minds--a biological basis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The appreciation of visual jokes in people with schizophrenia: a study of 'mentalizing' ability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Changing concepts of schizophrenia and the ahistorical fallacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Developmentally moderated expressions of the neuropathology underlying schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neuromotor precursors of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Child development risk factors for adult schizophrenia in the British 1946 birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Childhood-onset schizophrenia. Progressive ventricular change during adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Progressive reduction of temporal lobe structures in childhood-onset schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regional brain volume change over the life-time course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

From neuropathology to neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Obstetric factors, urbanization and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Obstetric complications and congenital malformation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cerebral lateralization is delayed in children who later develop schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Defining treatment refractoriness in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neuroleptic withdrawal in schizophrenic patients. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurocognitive impairment in schizophrenia and how it affects treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Serotonergic basis of antipsychotic drug effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Recent advances in the pharmacotherapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Antipsychotic drug affinities at alpha2-adrenoceptor subtypes in post-mortem human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The acute effect of sertindole on brain 5-HT2, D2 and ?1 receptors (ex vivo radioreceptor binding studies)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Pharmacologic strategies for augmenting cognitive performance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Clozapine reverses the spatial working memory deficits induced by FG7142 in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

New Antipsychotics: Classification, Efficacy, and Adverse Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Serotonin-dopamine interactions in the nigrostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The role of serotonin in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effects of anticholinergic medication on memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Clozapine is a potent and selective muscarinic M4 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Differential effects of chronic haloperidol and clozapine administration on glutamatergic transmission in the fronto-parietal cortex in rats: microdialysis and electrophysiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Haloperidol abolished glutamate release evoked by photic stimulation of the visual cortex in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Duration-dependent increase in striatal glutamate following prolonged fluphenazine administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Intracellular modulation of NMDA receptor function by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

1 reference

7 January 2021

The genetics of schizophrenia: a current, genetic-epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Independent diagnoses of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Interaction between genetic vulnerability and family environment: the Finnish adoptive family study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The Iowa 500. II. A blind family history comparison of mania, depression, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Adoption studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Twin concordance for operationally defined schizophrenia. Confirmation of familiality and heritability.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia in the National Academy of Sciences-National Research Council Twin Registry: a 16-year update.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Twin studies in schizophrenia with special emphasis on concordance figures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Identification of the cystic fibrosis gene: genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosomes 19 and 20 report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosome 13 workshop report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosome 4 Workshop Summary: Sixth World Congress on Psychiatric Genetics, Bonn, Germany, October 6-10, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosome 6 workshop report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosomes 8 and 10 workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Report of the chromosome 18 workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosome 22 workshop report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Sixth World Congress of Psychiatric Genetics X chromosome workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Linkage and associated studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The future of genetic studies of complex human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genomic scan for genes predisposing to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Absence of linkage between schizophrenia and the dopamine D4 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Molecular genetic studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The physiological role of 5-HT2A receptors in working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neurotrophin-3 gene polymorphisms and schizophrenia: no evidence for linkage or association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosomal aberrations and schizophrenia. Autosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

High rates of schizophrenia in adults with velo-cardio-facial syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosomal abnormalities and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A Polymorphic Genomic Duplication on Human Chromosome 15 Is a Susceptibility Factor for Panic and Phobic Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Disruption of two novel genes by a translocation co-segregating with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Chromosome 1 loci in Finnish schizophrenia families

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

No major schizophrenia locus detected on chromosome 1q in a large multicenter sample

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neuregulin 1 and susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Association of neuregulin 1 with schizophrenia confirmed in a Scottish population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The frustrating search for schizophrenia genes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Candidate-gene association studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Schizophrenia: genes and environment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis".

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The genes for major psychosis: aberrant sequence or regulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Psychopathology in women and men: focus on female hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Human morbid genetics revisited: relevance of epigenetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic basis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Model misspecification and multipoint linkage analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Turning point in the design of linkage studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A haplotype-based 'haplotype relative risk' approach to detecting allelic associations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

What association analysis can and cannot tell us about the genetics of complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Searching for genetic determinants in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Modeling dopamine system dysfunction in experimental animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Use of toxins to disrupt neurotransmitter circuitry in the developing brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The behavior of APO-SUS rats in animal models with construct validity for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The sigma receptor as a ligand-regulated auxiliary potassium channel subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Kainic acid lesions in adult rats as a model of schizophrenia: changes in auditory information processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Cytotoxic lesion of the medial prefrontal cortex abolishes the partial reinforcement extinction effect, attenuates prepulse inhibition of the acoustic startle reflex and induces transient hyperlocomotion, while sparing spontaneous object recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A direct projection from Ammon's horn to prefrontal cortex in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Excitatory Amino Acid Pathway from the Hippocampus to the Prefrontal Cortex. Contribution of AMPA Receptors in Hippocampo-prefrontal Cortex Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prolonged isolation and alcohol effect on avoidance learning in two strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: implications for a neurodevelopmental animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Sensory gating in rats depleted of dopamine as neonates: potential relevance to findings in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prenatal malnutrition and development of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Genetic animal models: focus on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Profound neuronal plasticity in response to inactivation of the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Role of reelin in the control of brain development1Published on the World Wide Web on 21 October 1997.1

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Coloboma hyperactive mutant exhibits delayed neurobehavioral developmental milestones.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Identification of the phenotype in psychiatric genetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Patterns of brain activation in people at risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Moving beyond findings: concepts and model-building in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

A critical review of research on psychosocial treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

Affective reactivity of language symptoms, startle responding, and inhibition in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900035-6

7 January 2021

10.1016/S0149-7634(03)00035-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12788337